Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05673018 · ClinicalTrials.gov registry record · NA
Galleri® in the Medicare Population.
A NA study of Cancer, sponsored by GRAIL.
- Recruiting
- Registry status
- NA
- Development phase
- 50,000
- Enrollment target
- 20
- Study locations
NCT05673018: Recruiting NA study of Cancer, sponsored by GRAIL.
NCT05673018 is a NA study of Cancer that is actively recruiting participants, run by GRAIL. The registered enrollment target is 50,000 participants, above the 3,410-participant average among 615 other Cancer trials with a reported enrollment target (1366% higher). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05673018, a NA study of Cancer, is actively recruiting participants, sponsored by GRAIL.
- RECRUITING
- Registry status
- NA
- Development phase
- 50,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.
Conditions Studied
Interventions
- DEVICE Multi-Cancer Early Detection Test (Galleri®)
Study Locations (20)
California
- Sutter Valley Hospitals Auburn - Auburn
- Sutter Valley Hospitals Davis - Davis
- Sutter Valley Hospitals Elk Grove - Elk Grove
- Long Beach Memorial Orange Coast - Fountain Valley
- Long Beach Memorial Saddleback - Laguna Hills
- Long Beach Memorial Atlantic - Long Beach
- Sutter Valley Hospitals Modesto - Modesto
- Sutter Valley Hospitals PAMF Sutter - Palo Alto
- Sutter Valley Hospitals Roseville - Roseville
- Sutter Valley Hospitals Alhambra - Sacramento
- Sutter Valley Hospitals Capitol Pavilion - Sacramento
- University of California San Francisco Health System - San Francisco
- Sutter Valley Hospitals Santa Barbara - Santa Barbara
- Sutter Valley Hospitals PAMF Santa Cruz - Santa Cruz
- Sutter Health Santa Rosa - Santa Rosa
- Sutter Valley Hospitals PAMF Sunnyvale - Sunnyvale
- Sutter Valley Hospitals Fairfield - Vallejo
Georgia
- Morehouse School of Medicine Atlanta - Atlanta
- Morehouse School of Medicine Lee Street - Atlanta
- Morehouse School of Medicine Princeton Lakes - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,000 participants |
| Start Date | 2024-07-12 |
| Est. Completion | 2030-09 |
| Phase | NA |
What NCT05673018 shows while recruiting
NCT05673018 is an interventional study that assigns participants to a tested intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 3,410-participant average among 615 other Cancer trials with a reported enrollment target (1366% higher).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Multi-Cancer Early Detection Test (Galleri®) is the first listed.
NCT05673018 names 20 study sites across 2 states, led by California, Georgia.
Frequently Asked Questions
What is clinical trial NCT05673018 about?
NCT05673018 is a clinical study titled "Galleri® in the Medicare Population.". This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.
What is the current status of trial NCT05673018?
This trial is currently recruiting. It is a NA study. The enrollment target is 50,000 participants. The study started on 2024-07-12. Estimated completion is 2030-09.
What conditions does trial NCT05673018 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT05673018?
The interventions under investigation include: Multi-Cancer Early Detection Test (Galleri®) (DEVICE).
Who is sponsoring clinical trial NCT05673018?
This trial is sponsored by GRAIL, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05673018 being conducted?
This trial has 20 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05673018's enrollment target sits among peer trials
50,000 8th of 615 higher than 606 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- NCT04629586 · 50,000 participants
The T1D Exchange Registry
- NCT05497518 · 50,000 participants
The KidneyCARE (Community Access to Research Equity) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI